Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
Titel:
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
Auteur:
Usmani, Saad Z. Mateos, Maria-Victoria Hungria, Vania Iida, Shinsuke Bahlis, Nizar J. Nahi, Hareth Magen, Hila Cavo, Michele Hulin, Cyrille White, Darrell De Stefano, Valerio Fastenau, John Slavcev, Mary Heuck, Christoph Qin, Xiang Pei, Huiling Masterson, Tara Lantz, Kristen Gries, Katharine S.